What we know

What we know

What we know

The SMC team produces explanatory articles on topical issues to answer society’s questions, with the necessary context and depth.

What is the status of Hipra's Spanish anticovid vaccine?

The European Medicines Agency (EMA) is still considering the approval of Hipra's SARS-CoV-2 vaccine. In mid-May, Hipra said it was ready to "have the vaccine available in a few days" following EMA approval, which it expected by the middle of this year, but which is being delayed until at least after July, as Elia Torroella, Hipra's R&D and Registration Director, explained at a breakfast briefing organised by the company today. 

What we know about the health impact of drinking a glass of wine a day

"The level of alcohol consumption that does not harm health is zero," says a review of dozens of studies conducted in recent years on the effect of light drinking. The 20 or so authors of the paper, and other experts, insist that "alcohol is carcinogenic from the first drink". In their view, this message should be conveyed more clearly to the public.

 

0